Press Releases Evotec SE

Equities

EVT

DE0005664809

Biotechnology & Medical Research

Market Closed - Xetra Other stock markets 09:05:25 05/06/2026 pm IST			5-day change	1st Jan Change
4.932 ^EUR	-3.58%		-6.59%	-9.50%

13/05	Evotec raises fresh capital for restructuring - shares under pressure	DP
13/05	Evotec shares slide following convertible bond issue and equity placement	DP

Press Releases

02/06	Evotec Appoints Rui Wang as Head of Global In Silico and AI	EQ
26/05	Evotec : Letter of the Chair of Supervisory Board to the Shareholders of Evotec 116,952 KB	PU
22/05	Evotec SE: Dr. Cord Dohrmann, sell	EQ
13/05	Evotec SE Successfully Placed €116.1 Million Convertible Bonds	EQ
12/05	Evotec SE launches approximately EUR 125 million convertible bond offering	EQ
08/05	Evotec : Current Company Presentation 1.325 MB (2026 05 EVT Company Presentation)	PU
07/05	Evotec : Convening and Agenda of the Annual General Meeting, PDF (AGM Agenda EN)	PU
06/05	Evotec : Presentation Analyst Call Q1 2026 results, 6 May 2026 (20260506 Presentation Q1 Results FINAL)	PU
06/05	Evotec : Interim Statement Q1 2026, PDF (Interim Statement Q1 2026 English)	PU
06/05	Evotec Announces First Quarter 2026 Results: Building Transformation Momentum	EQ
05/05	Evotec : Modified remuneration system of the Management Board on agenda item 9, PDF (Evotec Remuneration System 2026 EN)	PU
05/05	Evotec : Articles of Association, PDF (2026 02 10 Evotec SE Articles of Association english)	PU
05/05	Evotec : Power of attorney to the proxies of the Company, PDF (Power of attorney to the proxies of the Company)	PU
05/05	Evotec : Revocation of proxy, PDF (Revocation of proxy)	PU
05/05	Evotec : Data Protection Information for Shareholders, PDF (Evotec Data protection)	PU
05/05	Evotec : Convening and Agenda of the Annual General Meeting, PDF (2026 05 04 AGM Agenda EN)	PU
05/05	Evotec : Information pursuant to § 125 para. 1 AktG in conjunction with. §125 para. 5 AktG, Article 4 para. 1 as well as Table 3 of the Annex to the Implementing Regulation (EU) 2018/1212, PDF (Evotec Informationen pursuant to %C2%A7 125 AktG as well as Table 3 of the Annex to the Implementing Regulation EU 20181212)	PU
05/05	Evotec : Integrated Annual Report 2025, PDF (Evotec Integrated Annual Report 2025)	PU
05/05	Evotec : Corporate governance declaration for the 2025 financial year, PDF (Declaration on corporate governance 2025 EN)	PU
05/05	Evotec : Explanatory notes on the resolution less item 1, PDF (Evotec information item 1)	PU
05/05	Evotec : Remuneration report 2025 on agenda item 5, PDF (Remuneration Report 2025 EN)	PU
05/05	Evotec : Curriculum vitae of the candidates proposed for election on agenda item 7, PDF (Curriculum Vitae of candidates proposed Agenda Item 7)	PU
05/05	Evotec : Explanation of shareholders' rights, PDF (Evotec explanations of the rights of shareholders)	PU
05/05	Evotec SE: Paul Hitchin, Restricted shares granted as Short Term Variable Incentive (Bonus) for 2025 pursuant Evotec’s remuneration system.	EQ
05/05	Evotec SE: Aurélie Dalbiez, Restricted shares granted as Short Term Variable Incentive (Bonus) for 2025 pursuant Evotec’s remuneration system.	EQ